OliX Pharmaceuticals, Inc.
OliX Pharmaceuticals, Inc. has 1 licensing announcement in this dataset, dated 2026-08-21.
- Country / operating region
- South Korea
- Ticker
- 226950.KQ
- Headquarters
- 查無
- Founded
- 查無
- Business
- RNAi therapeutics research and development
- Website
- www.olixpharma.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| Two undisclosed siRNA sequences | 查無 | other | 查無 | 2026-08-21 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Jiangsu Hansoh Pharmaceuticals Group Co., Ltd. | Two undisclosed siRNA sequences | 查無 | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Jiangsu Hansoh Pharmaceuticals Group Co., Ltd. | Worldwide | Running royalties linked to product sales; rate not disclosed. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無